ArticleMammalian genome : official journal of the International Mammalian Genome Society2025
Identification of biomarkers associated with phagocytosis regulatory factors in coronary artery disease using machine learning and network analysis.
Article in Mammalian genome : official journal of the International Mammalian Genome Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoronary artery disease (CAD) is the leading cause of death worldwide, and aberrant phagocytosis may be involved in its development. Understanding this aspect may provide new avenues for prompt CAD diagnosis.
methodsCAD-related information was obtained from Gene Expression Omnibus datasets GSE66360, GSE113079, and GSE59421. We identified 995 upregulated and 1086 downregulated differentially expressed genes (DEGs) in GSE66360. Weighted gene co-expression network analysis revealed a module of 503 genes relevant to CAD. Using clusterProfiler, we revealed 32 CAD-related PRFs. Eight candidate genes were identified in a protein-protein interaction network. Machine learning algorithms identified CAD biomarkers that underwent gene set enrichment analysis, immune cell analysis with CIBERSORT, microRNA (miRNA) prediction using the miRWalk database, transcription factor (TF) level predication through ChEA3, and drug prediction with DGIdb. Cytoscape visualized the miRNA -mRNA- TF, miRNA-single nucleotide polymorphism-mRNA, and biomarker-drug networks.
resultsIL1B, TLR2, FCGR2A, SYK, FCER1G, and HCK were identified as CAD biomarkers. The area under the curve of a diagnostic model based on the six biomarkers was > 0.7 for the GSE66360 and GSE113079 datasets. Gene set enrichment analysis revealed differences in their biological pathways. CIBERSORT revealed that 10 immune cell types were differentially expressed between the CAD and control groups. The TF-mRNA-miRNA network showed that has-miR-1207-5p regulates HCK and FCER1G expression and that RUNX1 and SPI may be important TFs. Ninety-five drugs were predicted, including aspirin, which influenced ILIB and FCERIG.
conclusionIn this study, six biomarkers (IL1B, TLR2, FCGR2A, SYK, FCER1G, and HCK) related to CAD phagocytic regulatory factors were identified, and their expression regulatory relationships in CAD were further studied, providing a deeper understanding of the pathogenesis, diagnosis, and potential treatment strategies of CAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.